Transvaginal mesh is a dangerous implant used to treat stress urinary incontinence (SUI) and pelvic organ prolapse (POP) in women. Transvaginal mesh devices were represented to be safe and effective for women suffering from POP and SUI, but a staggering number of women experienced serious complications from the implants, such as infection, erosion of vaginal tissues, and organ perforation.
Importantly, plaintiffs achieved a significant victory as Johnson & Johnson (“J & J”), a prominent manufacturer of such implants, agreed to settle four cases for the first time since the litigation against them began. Although the details of the settlements are confidential and do not constitute an admission of wrongdoing the settlements demonstrate that in some cases, J & J is willing to settle mesh lawsuits filed against it. The company currently faces more than 23,000 lawsuits over the mesh implants, and the settlements are a step in the right direction for plaintiffs.
